Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
- 30 September 2008
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 52 (3), 486-493
- https://doi.org/10.1053/j.ajkd.2008.02.297
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Renal Allograft Protection with Angiotensin II Type 1 Receptor Antagonists L.American Journal of Transplantation, 2007
- Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney diseaseKidney International, 2006
- Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathyKidney International, 2006
- The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseKidney International, 2005
- Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to PerspectivesKidney and Blood Pressure Research, 2005
- Aldosterone in the development and progression of renal injuryKidney International, 2004
- Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 casesBMJ, 2003
- Rapid colorimetric assay of β-galactosidase and N-acetyl-β-glucosaminidase in human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Procedures for Detecting Outlying Observations in SamplesTechnometrics, 1969